BenevolentAI
AI drug discovery platform using biomedical knowledge graphs and machine learning
About BenevolentAI
BenevolentAI combines biomedical knowledge graphs and proprietary ontologies with machine learning to identify drug targets and predict how candidate molecules will behave in the body, focusing on diseases with limited treatment options. Researchers use it to mine scientific literature, clinical data, and genomic databases for connections that humans might overlook. Its Qor product serves as an always-on strategic function for biopharma decision makers and life science consultancies.
Screenshots
Commonly Cited Strengths & Limitations
Limitations
- Lead dermatitis candidate produced disappointing phase 2 results
- Repeated layoffs, office closure, and leadership turnover
- Delisted from Euronext Amsterdam and taken private in 2025
- Computational target identification still faces the same high-attrition clinical trial process
Common Use Cases
- Identifying drug targets for hard-to-treat diseases
- Mining scientific literature and genomic databases for research insights
- Predicting candidate molecule behavior in the body
Details
- Pricing Model
- Paid
- Category
- AI & Machine Learning
Key Features
- Biomedical knowledge graphs
- Proprietary ontologies
- Drug target identification
- Molecule behavior prediction
- Scientific literature mining
- Clinical and genomic data analysis
Technical Details
- Target Market
- B2B
Real Pricing from Verified Users
See what people actually pay for BenevolentAI
Reviews
0 reviews
No reviews yet. Be the first to share your experience!
Switching Stories
Real migration experiences with BenevolentAI
Discussion
Ask questions, share tips, or discuss this tool with other users.
No discussion yet. Start the conversation!
Top BenevolentAI Alternatives
Compare similar tools in AI & Machine Learning
Agentic CLI coding tool by Anthropic
More in AI & Machine Learning
The agentic IDE powered by Codeium AI